Lumanity is a co-author of four scientific posters being presented at this meeting.
- Indirect Treatment Comparison (ITC) of Recombinant C1 Inhibitor and Sebetralstat for Hereditary Angioedema On-Demand Therapy
ePoster ID: R081
Friday, November 7, 4:05:00 PM ET - Re-Analysis of Recombinant C1 Inhibitor (rhC1-INH) Clinical Data With Contemporary Time-to-Event Endpoint Definitions
ePoster ID: R098
Friday, November 7, 5:05:00 PM ET - Clinician Perspectives on Modifiers of Observed Treatment Effect in On-Demand Hereditary Angioedema (HAE) Therapy Trials
ePoster ID: R112
Saturday, November 8, 12:15:00 PM ET - Mapping Patient-Reported Outcome Measures Across Clinical Trials in Hereditary Angioedema (HAE)
Poster ID: R116
Sunday, November 9, 11:45:00 AM ET